Shuli Li
Impact in
- Cell Biology top 0.5%
- melanin and skin pigmentation
- Hematology top 1%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
Papers in
- Cell Biology 52
- melanin and skin pigmentation 52
- Hematology 48
- Hematopoietic Stem Cell Transplantation 35
- Acute Myeloid Leukemia Research 10
- Co-authors
- Chunying Li (59 shared papers)Michael Thornton Longaker (13 shared papers)Tianwen Gao (33 shared papers)Natalina Quarto (10 shared papers)Jianru Chen (23 shared papers)Robert J. Soiffer (29 shared papers)Yinghan Wang (14 shared papers)Xiuli Yi (25 shared papers)
- Journals
- Transplantation and Cellular Therapy (19 papers)Blood (19 papers)Journal of Clinical Oncology (7 papers)PLoS ONE (6 papers)Cancer (6 papers)
- Partner nations
- United StatesChinaItaly
In The Last Decade
Shuli Li
216 papers receiving 8.6k citations
Shuli Li's Hit Papers
Peers
Comparison fields: 5 of 137
- Cell Biology 1.4k
- Hematology 1.3k
- Otorhinolaryngology 487
- Rheumatology 653
- Cancer Research 562
Countries citing papers authored by Shuli Li
This map shows the geographic impact of Shuli Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuli Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuli Li more than expected).
Fields of papers citing papers by Shuli Li
This network shows the impact of papers produced by Shuli Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuli Li. The network helps show where Shuli Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Shuli Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 220 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx— ECOG-ACRIN Cancer Research Group Hit paper breakdown → | 2017 | 385 |
| 2 | 2020 | 239 | |
| 3 | 2020 | 215 | |
| 4 | 2020 | 213 | |
| 5 | 2014 | 207 | |
| 6 | Anatomically distinct fibroblast subsets determine skin autoimmune patterns Hit paper breakdown → | 2021 | 207 |
| 7 | 2015 | 197 | |
| 8 | 2018 | 184 | |
| 9 | 2016 | 166 | |
| 10 | 2006 | 165 | |
| 11 | 2020 | 165 | |
| 12 | 2016 | 162 | |
| 13 | 2006 | 154 | |
| 14 | 2020 | 143 | |
| 15 | 2005 | 137 | |
| 16 | 2009 | 135 | |
| 17 | 2019 | 130 | |
| 18 | 2019 | 124 | |
| 19 | 2019 | 116 | |
| 20 | 2020 | 116 |
About Shuli Li
Shuli Li is a scholar working on Cell Biology, Hematology, Rheumatology, Oncology and Immunology, having authored 220 papers that have together received 8.7k indexed citations. Recurring topics across this work include melanin and skin pigmentation (52 papers), Hematopoietic Stem Cell Transplantation (35 papers), Heterotopic Ossification and Related Conditions (16 papers), Acute Myeloid Leukemia Research (10 papers), Head and Neck Cancer Studies (8 papers), Craniofacial Disorders and Treatments (7 papers), Oral health in cancer treatment (7 papers) and Lymphoma Diagnosis and Treatment (7 papers). The work is most often cited by research in Cell Biology (1.4k citations), Hematology (1.3k citations), Otorhinolaryngology (487 citations), Rheumatology (653 citations) and Cancer Research (562 citations). Shuli Li has collaborated with scholars based in United States, China and Italy. Frequent co-authors include Chunying Li, Michael Thornton Longaker, Tianwen Gao, Natalina Quarto, Jianru Chen, Robert J. Soiffer, Yinghan Wang, Xiuli Yi, Zhe Jian and Corey S. Cutler. Their work appears in journals such as Transplantation and Cellular Therapy, Blood, Journal of Clinical Oncology, PLoS ONE and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.